Zealand Pharma A/S (OTCPK:ZLDPF)
$ 90.7 0 (0%) Market Cap: 5.64 Bil Enterprise Value: 5.21 Bil PE Ratio: 0 PB Ratio: 13.48 GF Score: 56/100

Q3 2022 Zealand Pharma A/S Earnings Call Transcript

Nov 10, 2022 / 03:00PM GMT
Release Date Price: $26.48
Operator

Good day, and thank you for standing by. Welcome to Zealand Pharma Results for Third Quarter 2022 Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Anna Krassowska. Please go ahead.

Anna Krassowska;S;VP of IR;Corporate Communications
Zealand Pharma A

/-&

Thank you, operator. Welcome, and thank you for joining us today to discuss Zealand's third quarter results for 2022. I'm Anna Krassowska, Vice President of Investor Relations and Corporate Communications at Zealand.

With me today to review the items on Slide 2 are the following members of Zealand's management team. Adam Steensberg, President and Chief Executive Officer; Henriette Wennicke, Chief Financial Officer; and David Kendall, Chief Medical Officer.

You can also find the related company announcement and supporting information on our website at zealandpharma.com.

I would like to point out, as

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot